Regenera (Biotechnology) Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Early Stage VC
- (Cancelled)
- Latest Deal Amount
-
$13.3M
- Investors
-
2
Regenera (Biotechnology) General Information
Description
Developer of a combined biomaterial and stem cell therapy designed for sub-acute spinal cord injury repair. The company's platform integrates an injectable resorbable hydrogel with autologous stem cells to provide trophic support to tissue plasticity, enabling the healthcare market to progressively lead damaged tissue toward self-regeneration and achieve cord functionality restoration.
Contact Information
Website
www.regenera.atCorporate Office
- Modecenterstrasse 22/D01
- Vienna, Vienna 1030
- Austria
Corporate Office
- Modecenterstrasse 22/D01
- Vienna, Vienna 1030
- Austria
Regenera (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 20-Sep-2024 | $13.3M | Cancelled | Startup | ||
| 2. Accelerator/Incubator | 28-Sep-2022 | Completed | Startup | |||
| 1. Seed Round | 11-Apr-2022 | Completed | Startup |
Regenera (Biotechnology) Patents
Regenera (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4777161-A1 | A double interpenetrating polymeric matrix hydrogel containing progenitor cells and biomolecules, for neuronal tissue repair | Pending | 12-Sep-2023 | ||
| WO-2025056722-A1 | A double interpenetrating polymeric matrix hydrogel containing progenitor cells and biomolecules, for neuronal tissue repair | Inactive | 12-Sep-2023 | ||
| JP-2026532214-A | A dual interpenetrating polymer matrix hydrogel for nerve tissue repair, containing progenitor cells and biomolecules. | Pending | 12-Sep-2023 | A61K47/32 |
Regenera (Biotechnology) Signals
Regenera (Biotechnology) Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| USI Startup Centre | Accelerator/Incubator | |||
| ILUM Tec GmbH | Corporation | Minority |
Regenera (Biotechnology) FAQs
-
When was Regenera (Biotechnology) founded?
Regenera (Biotechnology) was founded in 2021.
-
Where is Regenera (Biotechnology) headquartered?
Regenera (Biotechnology) is headquartered in Vienna, Austria.
-
What is the size of Regenera (Biotechnology)?
Regenera (Biotechnology) has 4 total employees.
-
What industry is Regenera (Biotechnology) in?
Regenera (Biotechnology)’s primary industry is Biotechnology.
-
Is Regenera (Biotechnology) a private or public company?
Regenera (Biotechnology) is a Private company.
-
What is Regenera (Biotechnology)’s current revenue?
The current revenue for Regenera (Biotechnology) is .
-
Who are Regenera (Biotechnology)’s investors?
USI Startup Centre and ILUM Tec GmbH have invested in Regenera (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process